BlackRock Institutional Trust’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $748M | Buy |
2,037,231
+19,389
| +1% | +$7.12M | 0.11% | 187 |
|
|
2016
Q3 | $811M | Buy |
2,017,842
+7,547
| +0.4% | +$3.03M | 0.13% | 162 |
|
|
2016
Q2 | $702M | Buy |
2,010,295
+49,006
| +2% | +$17.1M | 0.11% | 177 |
|
|
2016
Q1 | $707M | Buy |
1,961,289
+13,215
| +0.7% | +$4.76M | 0.12% | 170 |
|
|
2015
Q4 | $1.06B | Buy |
1,948,074
+9,653
| +0.5% | +$5.24M | 0.17% | 114 |
|
|
2015
Q3 | $902M | Buy |
1,938,421
+5,335
| +0.3% | +$2.48M | 0.16% | 124 |
|
|
2015
Q2 | $986M | Sell |
1,933,086
-82,743
| -4% | -$42.2M | 0.16% | 127 |
|
|
2015
Q1 | $910M | Buy |
2,015,829
+28,849
| +1% | +$13M | 0.14% | 142 |
|
|
2014
Q4 | $815M | Sell |
1,986,980
-17,113
| -0.9% | -$7.02M | 0.13% | 164 |
|
|
2014
Q3 | $723M | Sell |
2,004,093
-92,116
| -4% | -$33.2M | 0.12% | 166 |
|
|
2014
Q2 | $592M | Buy |
2,096,209
+35,120
| +2% | +$9.92M | 0.1% | 208 |
|
|
2014
Q1 | $619M | Sell |
2,061,089
-17,068
| -0.8% | -$5.13M | 0.11% | 190 |
|
|
2013
Q4 | $572M | Buy |
2,078,157
+29,453
| +1% | +$8.11M | 0.1% | 201 |
|
|
2013
Q3 | $641M | Buy |
2,048,704
+6,718
| +0.3% | +$2.1M | 0.12% | 162 |
|
|
2013
Q2 | $459M | Buy |
+2,041,986
| New | +$459M | 0.09% | 218 |
|